The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells.
Open accessAbstract
Highly purified, small dense splenic B cells from unstimulated mice showed increased expression of class II major histocompatibility complex (MHC) antigens and enhanced viability when cultured with affinity-purified recombinant interleukin 10 (rIL-10), compared with B cells cultured in medium alone. These responses were blocked by a monoclonal antibody (mAb) specific for IL-10, but not by an isotype-matched control antibody. IL-10 did not upregulate the expression of Fc epsilon receptors (CD23) or class I MHC antigens on small dense B cells or induce their replication as monitored by [3H]thymidine incorporation. While these B cell-stimulatory properties of IL-10 are also mediated by IL-4, the two cytokines appear to act independently in these assays; anti-IL-10 antibodies blocked IL-10 but not IL-4-mediated B cell viability enhancement, and vice versa. Similarly, since IL-4 upregulates CD23 on small dense B cells, the inability of IL-10 to do so argues against its acting via endogenously generated IL-4. Finally, IL-10 did not upregulate class II MHC antigens on B cells from X chromosome-linked immunodeficiency (XID) mice, while the same cells showed normal upregulation of class II antigens in response to IL-4. This report also extends our understanding of the relationship between IL-10 and the highly homologous Epstein-Barr virus (EBV)-encoded Bam HI fragment C rightward reading frame no. 1 (BCRFI) protein. It has previously been shown that BCRFI protein exhibits the cytokine synthesis inhibitory activity of IL-10. This report indicates that BCRFI protein also enhances in vitro B cell viability, but does not upregulate class II MHC antigens on B cells. One explanation for these data is that IL-10 contains at least two functional epitopes, only one of which has been conserved by EBV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Self-citationMosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Self-citationHomology of Cytokine Synthesis Inhibitory Factor (IL-10) to the Epstein-Barr Virus Gene BCRFI
Moore, K. W., Vieira, P., Fiorentino, D. F., Trounstine, M. L., Khan, T. A., & Mosmann, T. R. (1990) · Science · doi:10.1126/science.2161559 · Cited by 1,143
Self-citationProduction of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1
Ohara, J., & Paul, W. E. (1985) · Nature · doi:10.1038/315333a0 · Cited by 726
Molecular Regulation of B Lymphocyte Response
Kishimoto, T., & Hirano, T. (1988) · Annual Review of Immunology · doi:10.1146/annurev.iy.06.040188.002413 · Cited by 567
Expression of Interleukin-10 Activity by Epstein-Barr Virus Protein BCRF1
Hsu, D.-H., Malefyt, R. D. W., Fiorentino, D. F., Dang, M.-N., Vieira, P., deVries, J., Spits, H., Mosmann, T. R., & Moore, K. W. (1990) · Science · doi:10.1126/science.2173142 · Cited by 535
Self-citationSteeg, P. S., Moore, R. N., Johnson, H. M., & Oppenheim, J. J. (1982) · The Journal of experimental medicine · doi:10.1084/jem.156.6.1780 · Cited by 475
Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes.
Defrance, T., Aubry, J. P., Rousset, F., Vanbervliet, B., Bonnefoy, J. Y., Arai, N., Takebe, Y., Yokota, T., Lee, F., & Arai, K. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.6.1459 · Cited by 446
Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor.
Noelle, R., Krammer, P. H., Ohara, J., Uhr, J. W., & Vitetta, E. S. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.19.6149 · Cited by 435
Regulation of B-Cell Growth and Differentiation by Soluble Factors
Howard, M., & Paul, W. E. (1983) · Annual Review of Immunology · doi:10.1146/annurev.iy.01.040183.001515 · Cited by 430
Self-citationProduction of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10
O'Garra, A., Stapleton, G., Dhar, V., Pearce, M., Schumacher, J., Rugo, H., Barbls, D., Stall, A., Cupp, J., Moore, K., et al. (1990) · International Immunology · doi:10.1093/intimm/2.9.821 · Cited by 344
Self-citationHayakawa, K., Hardy, R. R., & Herzenberg, L. A. (1986) · European Journal of Immunology · doi:10.1002/eji.1830160423 · Cited by 301
Interleukin-induced increase in Ia expression by normal mouse B cells.
Roehm, N. W., Leibson, H. J., Zlotnik, A., Kappler, J., Marrack, P., & Cambier, J. C. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.3.679 · Cited by 292
Lowenthal, J. W., Castle, B. E., Christiansen, J., Schreurs, J., Rennick, D., Arai, N., Hoy, P., Takebe, Y., & Howard, M. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.2.456 · Cited by 242
Self-citationKikutani, H., Suemura, M., Owaki, H., Nakamura, H., Sato, R., Yamasaki, K., Barsumian, E. L., Hardy, R. R., & Kishimoto, T. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.5.1455 · Cited by 232
‘B-cell factors’ are pleiotropic
O'Garra, A., Umland, S., De France, T., & Christiansen, J. (1988) · Immunology Today · doi:10.1016/0167-5699(88)91259-5 · Cited by 228
Hasler, F., Bluestein, H. G., Zvaifler, N. J., & Epstein, L. B. (1983) · The Journal of Experimental Medicine · doi:10.1084/jem.157.1.173 · Cited by 141
Hudak, S. A., Gollnick, S. O., Conrad, D. H., et al. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.13.4606 · Cited by 136
Mond, J. J., Carman, J., Sarma, C., Ohara, J., & Finkelman, F. D. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.11.3534 · Cited by 133
Lotz, M., Tsoukas, C. D., Fong, S., Carson, D. A., & Vaughan, J. H. (1985) · European Journal of Immunology · doi:10.1002/eji.1830150518 · Cited by 111
Identification of a novel thymocyte growth-promoting factor derived from B cell lymphomas
Suda, T., O’Garra, A., MacNeil, I. A., Fischer, M., Bond, M. W., & Zlotnik, A. (1990) · Cellular Immunology · doi:10.1016/0008-8749(90)90200-b · Cited by 91
Cross, D., & Cambier, J. C. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.2.432 · Cited by 56
Molecular Regulation Of B Lymphocyte Response
Kishimoto, T. (1988) · Annual Review of Immunology · doi:10.1146/annurev.immunol.6.1.485 · Cited by 39
Cited by
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Self-citationInterleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,274
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
“cytotoxic T cells (5), mast cells (6), B cells (7), and macrophages (3).”
de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.915 · Cited by 1,930
Self-citationAN INVESTIGATION OF POLYMORPHISM IN THE INTERLEUKIN‐10 GENE PROMOTER
Turner, D. M., Williams, D. M., Sankaran, D., Lazarus, M., Sinnott, P. J., & Hutchinson, I. V. (1997) · European Journal of Immunogenetics · doi:10.1111/j.1365-2370.1997.tb00001.x · Cited by 1,717
Metadata
- Authors
- Go, N. F., Castle, B. E., Barrett, R., Kastelein, R., Dang, W., Mosmann, T. R., Moore, K. W., & Howard, M.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1990-12-01
- Volume
- 172
- Issue
- 6
- Pages
- 1625-1631
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W1981533854
- Cited by
- 475
- References
- 23
- FWCI
- 10.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.